Fulcrum Therapeutics Inc (NASDAQ: FULC)
Recent developments with Fulcrum Therapeutics Inc (FULC) have led to the company’s beta value being reach 3.19 cents.
Shaun Noe
On Tuesday, Fulcrum Therapeutics Inc (NASDAQ: FULC) was -7.84% drop from the session before settling in for the closing price ...
$1.30M in average volume shows that Fulcrum Therapeutics Inc (FULC) is heading in the right direction
Steve Mayer
Fulcrum Therapeutics Inc (NASDAQ: FULC) kicked off on Monday, up 3.54% from the previous trading day, before settling in for ...
Fulcrum Therapeutics Inc (FULC) kicked off at the price of $11.79: Venture capitalists have an exciting new opportunity
Sana Meer
Fulcrum Therapeutics Inc (NASDAQ: FULC) on Tuesday, plunged -7.75% from the previous trading day, before settling in for the closing ...
Fulcrum Therapeutics Inc (FULC) volume exceeds 0.85 million: A new investment opportunity for investors
Zack King
Fulcrum Therapeutics Inc (NASDAQ: FULC) kicked off on Tuesday, down -3.25% from the previous trading day, before settling in for ...
Fulcrum Therapeutics Inc (FULC) volume exceeds 0.87 million: A new investment opportunity for investors
Zack King
Fulcrum Therapeutics Inc (NASDAQ: FULC) on Tuesday, soared 6.26% from the previous trading day, before settling in for the closing ...
